HERCULES, Calif., December 3, 2007 – Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, today announced the availability of Bio-Rad’s technical note (bulletin 5540), which describes the screening, ranking, and epitope mapping of anti-human IL-9 supernatants.
